Clinical trial
Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel
NCT00028132 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00028132 |
|---|---|
| Title | Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel |
| Official title | Phase I Safety and Acceptability Study of the Vaginal Microbicide Agent PMPA Gel |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Tenofovir |
| Enrollment | 120 |
| Completion | Dec 1, 2005 |
| First posted | Dec 14, 2001 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: